FDA Clearance Tracker · P820060
ABBOTT AFP-EIA DIAGNOSTIC KIT FOR CANCER
Last checked: Nov 20, 2026Latest source record: Jun 21, 1983 (this decision)Source: openFDAMethods & limitations
Decided
Jun 21, 1983
Approval withdrawn
Time to decision
312 days
Received Aug 13, 1982. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P820060
- Device name
- ABBOTT AFP-EIA DIAGNOSTIC KIT FOR CANCER
- Applicant
- Abbott Laboratories
- Applicant location
- Abbott Park, IL
- Received
- Aug 13, 1982
- Decided
- Jun 21, 1983
- Decision
- Approval withdrawn
- Supplements
- 28 in FDA's data for this PMA. See them on the FDA record
Device type
- Device class
- Class III
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code LOK (KIT, TEST, ALPHA-FETOPROTEIN FOR NEURAL TUBE DEFECTS).
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
Other decisions for Abbott Laboratories
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- Anti-HCV Next510(k)
K262156 · Decided Sep 23, 2026 · 89 days after receipt
Device type: Assay, Enzyme Linked Immunosorbent, Hepatitis C Virus (MZO) · Laboratory Medicine & Pathology
- Anti-HCV Next510(k)
K252424 · Decided Apr 28, 2026 · 270 days after receipt
Device type: Assay, Enzyme Linked Immunosorbent, Hepatitis C Virus (MZO) · Laboratory Medicine & Pathology
- ARCHITECT iGentamicin510(k)
K243500 · Decided Jul 9, 2025 · 239 days after receipt
Device type: Enzyme Immunoassay, Gentamicin (LCD) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.